While fewer studies asked about the interaction of GLP-1-based therapeutics and reproductive axis in men, there is some evidence suggesting improvements in reproductive functions at least in the context of improving obesity. The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.